IMC Chicago’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.73M Buy
396,500
+105,200
+36% +$1.83M ﹤0.01% 1383
2025
Q4
$3.43M Buy
291,300
+66,100
+29% +$849K ﹤0.01% 2003
2025
Q3
$3.57M Buy
225,200
+81,400
+57% +$1.18M ﹤0.01% 1823
2025
Q2
$1.65M Buy
143,800
+80,100
+126% +$903K ﹤0.01% 2142
2025
Q1
$862K Sell
63,700
-12,700
-17% -$211K ﹤0.01% 2362
2024
Q4
$1.29M Sell
76,400
-800
-1% -$15.6K ﹤0.01% 2184
2024
Q3
$1.57M Buy
77,200
+18,100
+31% +$370K ﹤0.01% 1813
2024
Q2
$1.33M Sell
59,100
-33,000
-36% -$864K ﹤0.01% 1795
2024
Q1
$2.42M Buy
+92,100
New +$2.62M ﹤0.01% 1273

Other funds holding CC

IMC Chicago's CC Position: Q1 2026 in Review

IMC Chicago increased its Chemours (CC) stake by 175% in Q1 2026, buying an estimated $1.49M and bringing the position to 134,408 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

IMC Chicago first reported a position in CC in Q1 2024 and has held it in 6 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • IMC Chicago held 134,408 shares of Chemours worth $2.96M as of Q1 2026.
  • IMC Chicago bought 85,485 Chemours shares in Q1 2026, an estimated $1.49M.
  • Chemours made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #2234 holding.
  • IMC Chicago first reported a position in Chemours in Q1 2024 and has held it in 6 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.